CHORDIN, A SECRETED BMP ANTAGONIST
UCLA Technology Available For Licensing

The study of molecular mechanism within morphogenesis provides substantial therapeutic values since signal molecules involved in the process have potential utilities in regenerating tissues and organs. The chordin gene had previously been studied and its role in organ development elucidated in Xenopus. In situ hybridization data from the study indicated that the gene is expressed in the frog embryo head, trunk and tail organizer regions during gastrulation. The study also illustrated that the chordin protein product has the ability to modify mesoderm induction of embryonic cells, and is a potent neural inducer. In vivo, the chordin protein product can induce twinned embryos and completely restore head-to-tail development in which axis formation is experimentally prevented.

Researchers at UCLA had cloned Xenopus chordin and had produced the secreted protein successfully in an expression system. Chordin binds BMP-4 and BMP-7 with high specificity, preventing their binding to cognate receptors. The regenerative function of its ortholog in xenopus warrants chordin's use in medical applications that require regeneration, differentiation or repair of tissues. These may include: a) wound repair; b) neuronal regeneration or transplantation, c) supplementation of muscle differentiation, d) bone tissue repair and any other applications in which embryonic cellular processes are to be induced. A recent study with mouse embryonic stem cells has shown that ES cells treated with Chordin form neurons and nestin-positive neuroepithelial progenitors (Gratsch and O'Shea, 2002).

Reference: UCLA Case No. 1994-541 US Patent Number: 5,986,056 | 5,846,770

For additional technical details and current licensing
availability, please contact the following UCLA office:

UCLA Office of Intellectual Property
11000 Kinross Avenue, Suite #200
Los Angeles, CA 90095-7231
Tel: 310-794-0558 Fax: 310-794-0638
email: ncd@research.ucla.edu
Lead Inventor: Edward De Robertis

UCLA Technologies Available for Licensing
http://www.research.ucla.edu/tech

Copyright © 2002 The Regents of the University of California.

keywords: therapeutics uclancd ucla technologies intellectual property patents technology transfer invention business card